Skip to main content
Book cover

Novel Therapeutics for Rare Lymphomas

  • Book
  • © 2020

Overview

  • Discusses the clinical presentation, diagnosis, and treatment approach to rare lymphomas

  • Focuses on new diagnostic approaches, novel chemotherapy combinations, and new treatment modalities with novel therapeutics

  • Written for practicing oncologists, hematologists, fellows, and residents

  • Covers T-cell Lymphomas, B-cell Lymphomas, Indolent/Aggressive, and Aggressive/Highly Aggressive types of Lymphomas

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (14 chapters)

Keywords

About this book

This comprehensive volume reviews the clinical presentation, diagnosis, and treatment approach to rare lymphomas. There is particular emphasis placed on new diagnostic approaches, novel chemotherapy combinations, and treatment modalities with novel therapeutics. It highlights research advances in a group of diseases that are often overlooked, and serves as a single repository of information on the most recent advances in targeted small molecule inhibitors, monoclonal antibodies, immunotherapy, and CAR-T therapy as they pertain to rare types of lymphoma. Written for practicing oncologists, hematologists, fellows, and residents, Novel Therapeutics for Rare Lymphomas covers rare subtypes of lymphoma, including indolent and aggressive T-cell lymphomas and B-cell lymphomas.

Editors and Affiliations

  • Department of Medicine, Division of Hematology and Oncology, University of North Carolina at Chapel Hill, Chapel Hill, USA

    Christopher Dittus

About the editor

Christopher Dittus, DO, MPH

Assistant Professor of Medicine

Division of Hematology/Oncology, Lymphoma Program

University of North Carolina, Chapel Hill









Bibliographic Information

  • Book Title: Novel Therapeutics for Rare Lymphomas

  • Editors: Christopher Dittus

  • DOI: https://doi.org/10.1007/978-3-030-25610-4

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Nature Switzerland AG 2020

  • Hardcover ISBN: 978-3-030-25609-8Published: 09 December 2019

  • Softcover ISBN: 978-3-030-25612-8Published: 24 October 2020

  • eBook ISBN: 978-3-030-25610-4Published: 23 October 2019

  • Edition Number: 1

  • Number of Pages: X, 253

  • Number of Illustrations: 2 b/w illustrations, 20 illustrations in colour

  • Topics: Oncology, Hematology

Publish with us